Innovating for screening
Screening to prevent, treat and cure
Assistance in the
interpretation of data
Automate biological screening, improve its efficiency, reduce mortality, while reducing the cost of analysis
Integrative and scalable biomedical analysis solutions that we adapt to your needs
High analytical sensitivity
Low costs of analysis
Robustness and traceability
Latest news and eventsSee the latest news
Présentation de Biomaneo
Vidéo réalisée en partenariat avec le Pôle BFCare.
4th Global Congress on Sickle Cell Disease
Join Biomaneo & Shimadzu at the 4th Global Congress on Sickle Cell Disease taking place in Paris from June 16-18.
Biomaneo obtains ISO 13485:2016 certification and strengthens its quality team
A key step for the marketing of its In Vitro Diagnostic Devices (IVDD) and in the transition to the new 2017/746 regulation.
New NeoSickle installation
With this second installation, 80% of French samples are now analysed using the NeoSickle solution.
Biomaneo puts the spotlight on the training of young people...
By welcoming three new employees to its teams
Biomaneo obtains the "Label Initiative Remarquable"
We are pleased to announce that we have just joined the 1st community of impact entrepreneurs in France...
A new shareholder into our business
In Dijon, Biomaneo is collecting additional financial resources from BFC Croissance & Innovation to continue the development of screening...
2 great events in October
ASCAT & GG2020
6th European Congress on Mass Spectrometry - Salzburg (Austria)
Biomaneo participates in the 6th European Congress dedicated to the use of Mass Spectrometry in the Clinical Labs.